Hims Hers Stumbles Open as Regulatory Damage Hits Outlook
Hims & Hers Health fell after guiding Q1 2026 revenue below expectations, citing a $65 million headwind from regulato...
An index measures a segment of the stock market, aggregating prices or returns. Learn what it reveals about market trends.
27,998 articlesHims & Hers Health fell after guiding Q1 2026 revenue below expectations, citing a $65 million headwind from regulato...
Qualcomm exploded higher, gaining about 70% in a single month as it pivots toward AI data-center demand. Investors ar...
A long-time investor explains why AbbVie’s mix of rapidly growing immunology drugs and a dependable dividend keeps dr...
Rocket Lab shares hover near $67 as July odds tilt toward downside. This story breaks down what prediction markets be...
Tesla’s shares fall in 2026 as Reddit users grow increasingly bearish, prompting a broader rethink of the EV leader’s...
A leading CIO cautions that AI stock valuations may be stretched beyond sustainable growth. The article surveys what ...
A diversified cybersecurity ETF now holds CrowdStrike alongside 30 other rivals, offering broad exposure as AI-driven...
Applied Optoelectronics is poised to report Q4 FY2025 results after the close on Feb. 26, 2026. Analysts expect reven...
U.S. healthcare equities rise as firms deploy agentic AI to cut labor costs, lifting a group of AI-enabled healthcare...
Salesforce CRM faces a sharp sell-off even as its AI strategy shows real monetization. Here’s why traders are watchin...
Thor Industries reports a dramatic EPS surprise for Q2, with revenue rising modestly. Yet cash flow weakness and unev...
As markets navigate a choppy May, tax rules around capital gains loom large for traders. Holding periods can swing ta...